Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...
Vous n'êtes pas connecté
Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia.
Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...
Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by...
Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets,...
The research uncovers a novel variant in the MYO1D gene that is linked to laterality defects, congenital heart diseases, and sperm defects in humans.
Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies...
Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies...
New research from the University of Kentucky’s Sanders-Brown Center on Aging has revealed that the cognitive impairments seen in long COVID patients...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
According to the Australian Dyslexia Association, “Dyslexia is estimated to affect some 10% of the Australian population.” This squarely puts...